05 Jan 2013
(MENAFN) Deloitte issued a report that says that the Saudi pharmaceutical market would stand at the value of USD4.7 billion after three years, reported Saudi Gazette.
Deloitte explained that an annual 4.7 percent growth rate would lead to this growth by 2016.
Deloitte cited this growth to increase in population, government spending and the increasing interest in this market.
It is worth mentioning that the Saudi pharmaceutical market is one of the largest among Middle Eastern Countries.
05 Aug 2024
With the support of BBK, BIBF and BJA hold a graduation ceremony for journalists completing the training program
09 Jun 2024
BBK Successfully Closes USD Benchmark Bond Offering at $500 Million, in Collaboration with a Consortium of Regional and International Banks.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more